- Home
- APLM vs IPDN Comparison
APLM vs IPDN Comparison
Compare APLM & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLM
- IPDN
- Stock Information
- Founded
- APLM 2016
- IPDN 2003
- Country
- APLM United States
- IPDN United States
- Employees
- APLM N/A
- IPDN N/A
- Industry
- APLM Blank Checks
- IPDN EDP Services
- Sector
- APLM Finance
- IPDN Technology
- Exchange
- APLM Nasdaq
- IPDN Nasdaq
- Market Cap
- APLM 6.1M
- IPDN 5.2M
- IPO Year
- APLM N/A
- IPDN 2013
- Fundamental
- Price
- APLM $5.48
- IPDN $8.04
- Analyst Decision
- APLM
- IPDN
- Analyst Count
- APLM 0
- IPDN 0
- Target Price
- APLM N/A
- IPDN N/A
- AVG Volume (30 Days)
- APLM 33.5K
- IPDN 16.9M
- Earning Date
- APLM 09-16-2025
- IPDN 08-14-2025
- Dividend Yield
- APLM N/A
- IPDN N/A
- EPS Growth
- APLM N/A
- IPDN N/A
- EPS
- APLM N/A
- IPDN N/A
- Revenue
- APLM $198,000.00
- IPDN $6,459,379.00
- Revenue This Year
- APLM $415.15
- IPDN N/A
- Revenue Next Year
- APLM N/A
- IPDN N/A
- P/E Ratio
- APLM N/A
- IPDN N/A
- Revenue Growth
- APLM N/A
- IPDN N/A
- 52 Week Low
- APLM $3.66
- IPDN $0.97
- 52 Week High
- APLM $35.98
- IPDN $12.39
- Technical
- Relative Strength Index (RSI)
- APLM 49.97
- IPDN 80.79
- Support Level
- APLM $3.66
- IPDN $1.89
- Resistance Level
- APLM $6.37
- IPDN $12.39
- Average True Range (ATR)
- APLM 0.54
- IPDN 1.31
- MACD
- APLM -0.10
- IPDN 0.74
- Stochastic Oscillator
- APLM 67.17
- IPDN 58.57
About APLM Apollomics Inc.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates majority of its revenue from TalentAlly Network Segment.